Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of joining the study
- People who have been recently diagnosed with glioblastoma (a type of brain tumour) for the first time
- People for whom a treatment plan involving radiation therapy, chemotherapy, and TTFields (a device-based therapy) has been decided but not yet started
- People who have signed a written consent form agreeing to take part
- People who are willing and able to follow the study procedures and give informed consent before any study-related activities begin
- People who are enrolled in the French national health insurance system (Social Health Insurance in France)
Who may not be able to join:
- People whose health condition makes it unsafe to undergo the blood or tissue sampling procedures required by the study
- People for whom the TTFields medical device is not considered safe to use
- People who are already taking part in another clinical trial involving a treatment or therapy
- People who are pregnant or currently breastfeeding
- People with a known history of hepatitis B, hepatitis C, HIV, or AIDS
- People whose personal, family, geographic, or social circumstances may prevent them from giving proper consent or following the study procedures, as judged by the study investigator
- People who are under legal guardianship, court protection, or have had their freedom restricted by an administrative or legal order
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 05 31 15 54 45
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Survival (OS) defined as the time from inclusion until death from any cause or last follow-up (censored data).; Time to Progression (TTP) defined as the time from inclusion until progression. Patients without progression are censored at last follow-up.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.